(Q42643514)

English

Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study

scientific article published on January 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 November 2017

Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study (English)

1 reference

Europe PubMed Central

4 November 2017

author name string

Baeten D

1

1 reference

Europe PubMed Central

4 November 2017

Kruithof E

2

1 reference

Europe PubMed Central

4 November 2017

Van den Bosch F

3

1 reference

Europe PubMed Central

4 November 2017

Demetter P

4

1 reference

Europe PubMed Central

4 November 2017

Van Damme N

5

1 reference

Europe PubMed Central

4 November 2017

Cuvelier C

6

1 reference

Europe PubMed Central

4 November 2017

De Vos M

7

1 reference

Europe PubMed Central

4 November 2017

Mielants H

8

1 reference

Europe PubMed Central

4 November 2017

Veys EM

9

1 reference

Europe PubMed Central

4 November 2017

De Keyser F

10

1 reference

Europe PubMed Central

4 November 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

4 November 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

4 November 2017

44

1 reference

Europe PubMed Central

4 November 2017

1

1 reference

Europe PubMed Central

4 November 2017

186-195

1 reference

Europe PubMed Central

4 November 2017

Role of cytokines in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

Opportunities for immune modulation in the spondyloarthropathies with special reference to gut inflammation

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

Needle arthroscopy of the knee with synovial biopsy sampling: technical experience in 150 patients

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

Analysis of the cellular infiltrates and expression of cytokines in synovial tissue from patients with rheumatoid arthritis and reactive arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

Quantification of the cell infiltrate in synovial tissue by digital image analysis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

Intra-articular primatised anti-CD4: efficacy in resistant rheumatoid knees. A study of combined arthroscopy, magnetic resonance imaging, and histology

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

Synovial cytokine and growth factor regulation of MMPs/TIMPs: implications for erosions and angiogenesis in early rheumatoid and psoriatic arthritis patients.

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

Tumour necrosis factor alpha (TNF-alpha) interferes with Fas-mediated apoptotic cell death on rheumatoid arthritis (RA) synovial cells: a possible mechanism of rheumatoid synovial hyperplasia and a clinical benefit of anti-TNF-alpha therapy for RA.

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

Immunohistological analysis of synovial tissue for differential diagnosis in early arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

Memory B lymphocytes from secondary lymphoid organs interact with E-selectin through a novel glycoprotein ligand.

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

Molecular control of B Lymphocyte growth and differentiation

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C186%3A%3AAID-ANR25%3E3.0.CO%3B2-B

21 January 2018

Identifiers

10.1002/1529-0131(200101)44:1<186::AID-ANR25>3.0.CO;2-B

1 reference

Europe PubMed Central

4 November 2017

1 reference

Europe PubMed Central

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42643514&oldid=1964386393"